New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies

por Syam, Yasmin M., Anwar, Manal M., Abd El-Karim, Somaia S., Elokely, Khaled M., Abdelwahed, Sameh H.
Publicado 2022

New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies

por Syam, Yasmin M., Anwar, Manal M., Abd El-Karim, Somaia S., Elseginy, Samia A., Essa, Basma M., Sakr, Tamer M.
Publicado 2021

Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition

por Kamel, Nahla N., Aly, Hanan F., Fouad, Ghadha I., Abd El-Karim, Somaia S., Anwar, Manal M., Syam, Yasmin M., Elseginy, Samia A., Ahmed, Kawkab A., Booles, Hoda F., Shalaby, Mohamed B., Khalil, Wagdy K. B., Sandhir, Rajat, Deshwal, Sonam, Rizk, Maha Z.
Publicado 2023